A new approach to immunosuppression at the complement level-hypothesis
- 1 June 1988
- journal article
- research article
- Published by Elsevier in Medical Hypotheses
- Vol. 26 (2) , 135-137
- https://doi.org/10.1016/0306-9877(88)90067-9
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Human lymphocyte Hybridomas and Monoclonal AntibodiesPublished by Elsevier ,1986
- Suppression of the development of experimental allergic encephalomyelitis by suraminNeuropharmacology, 1985
- Complement Effector Mechanisms in Health and DiseaseJournal of Investigative Dermatology, 1985
- Treatment of vasculitis with chlorpromazine and dapsoneArchives of Dermatological Research, 1985
- Regulation of in vitro primary anti-DNP antibody production by functional subsets of T lymphocytes in man.The Journal of Immunology, 1981
- Observations on the Antigenicity and Clinical Effects of a Candidate Antipregnancy Vaccine: β-subunit of Human Chorionic Gonadotropin Linked to Tetanus ToxoidFertility and Sterility, 1980
- Chapter 20. Complement InhibitorsPublished by Elsevier ,1980
- Autoimmune Response to Acetylcholine Receptors in Myasthenia Gravis and Its Animal ModelPublished by Elsevier ,1979
- Experimental allergic encephalomyelitis in cobra venom factor—treated and C4‐deficient guinea pigsAnnals of Neurology, 1978
- Role of complement in the pathogenesis of experimental autoimmune myasthenia gravis.The Journal of Experimental Medicine, 1978